Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoi

Details Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoi Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoi

1986-07-23

1988-05-24

Jiles, Henry R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514256, 514332, 514336, 544333, 546264, 546283, 546284, 546333, 546335, A61K 3144, C07D21355, C07D40506, C07D40106

Patent

active

047466715

ABSTRACT:
Novel [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters, compositions containing the same, and methods of treating clinical conditions related with the production of thromboxane A.sub.2, prostacyclin and/or prostaglandins D.sub.2, E.sub.2 and F.sub.2.alpha..

REFERENCES:
patent: 4003734 (1977-01-01), Johnston
patent: 4145425 (1979-03-01), Baldwin
patent: 4396764 (1983-08-01), Tanaka et al.
patent: 4543413 (1985-09-01), Munro
Richardson, A. J., Med. Chem., 7(6), 1964, pp. 824-826.

Affiliated with

Also associated with

Rating

Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1058658